The founder of a nanotechnology company
was arrested Wednesday on fraud charges
after authorities said he accepted over $12
million from investors who were told NASA was
helping him develop a breathalyzer to detect
cancer and narcotics.
James Jeremy Barbera, 64, former chief executive
of Nanobeak Biotech Inc., originally called
Nanobeak, was released on $1 million bail after
appearing in Manhattan federal court, where
he faces conspiracy, securities and wire fraud
charges carrying a potential of decades in prison.
A message seeking comment was sent to
his lawyer.